In patients of group LC2 that had an NSCLC, a trend was observed that did not reach statistical significance.
← all excerpts
Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor.
1
—
—